New IBS-C Guidelines: A Multi-Symptom Approach for HCPs and Payers

Science & Innovation Webinar

Webinar Recorded on April 20, 2022 
Sponsored by AbbVie and Ironwood 

The goal of this webinar is to better understand how health care providers (HCPs) apply current evidence-based IBS treatment guideline recommendations while simultaneously navigating managed care criteria that influences the care of the patients with IBS-C. The target audience includes physicians, nurse practitioners, physician assistants, and pharmacists who care for patients living with IBS-C. In addition, the target audience includes medical directors, pharmacy directors, chief pharmacy officers, and other stakeholders with healthcare access decision making responsibilities.

At the conclusion of this webinar, participants will be able to:

1) Provide a brief overview of the pathophysiology and diagnosis of IBS
2) Describe the patient burden of IBS-C symptoms and its impact on healthcare utilization and costs (e.g., workplace productivity, absenteeism, etc.)
3) Outline the most recent guideline recommendations for treatment of global symptoms of IBS-C from the American College of Gastroenterology (ACG)
4) Describe the application of evidence-based guideline recommendations and managed care tools in treatment of a patient with IBS-C.

Speaker:

• Darren M. Brenner, MD, FACG, AGAF, RFF
  Associate Professor of Medicine and Surgery
  Irene D. Pritzker Foundation Research Scholar
  Director – Northwestern Neurogastromotility Program
  Northwestern University – Feinberg School of Medicine

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: